ESPR icon

Esperion Therapeutics

131 hedge funds and large institutions have $218M invested in Esperion Therapeutics in 2023 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

3% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

8.14% less ownership

Funds ownership: 72.23%64.1% (-8.1%)

Holders
131
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$10.3M
Puts
$2.4M
Net Calls
Net Calls Change

Top Buyers

1 +$9.57M
2 +$3.63M
3 +$3.63M
4
WCM
Whitefort Capital Management
New York
+$2.65M
5
Two Sigma Investments
Two Sigma Investments
New York
+$2.62M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.43M
27
$1.38M
28
$1.37M
29
$1.3M
30
$1.15M
31
$1.13M
32
$1.05M
33
$1.01M
34
$868K
35
$847K
36
$828K
37
$824K
38
$728K
39
$707K
40
$663K
41
$663K
42
$649K
43
$640K
44
$603K
45
$583K
46
$553K
47
$528K
48
$403K
49
$362K
50
$348K